Login / Signup

Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-β-Amyloid Immunotherapy: A Meta-analysis.

So Yeong JeongChong Hyun SuhWoo Hyun ShimJae-Sung LimJae-Hong LeeSang Joon Kim
Published in: Neurology (2022)
The overall incidences of ARIA-E and ARIA-H were 6.5% and 7.8%, respectively, and the pooled proportion of asymptomatic ARIA was 80.4%. The cohorts treated with aducanumab showed a significantly higher incidence of ARIA-E and ARIA-H (30.7% and 30.0%) compared with other drugs.
Keyphrases
  • risk factors
  • high resolution
  • mild cognitive impairment
  • clinical trial
  • randomized controlled trial
  • newly diagnosed
  • mass spectrometry
  • drug induced